The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(1H-indazol-3-yl)-1H-benzo[d]imidazole ID: ALA383990
PubChem CID: 135464491
Max Phase: Preclinical
Molecular Formula: C14H10N4
Molecular Weight: 234.26
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc2[nH]c(-c3n[nH]c4ccccc34)nc2c1
Standard InChI: InChI=1S/C14H10N4/c1-2-6-10-9(5-1)13(18-17-10)14-15-11-7-3-4-8-12(11)16-14/h1-8H,(H,15,16)(H,17,18)
Standard InChI Key: JTKFRFMSUBOCIQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 21 0 0 0 0 0 0 0 0999 V2000
1.3801 2.2445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0945 1.8320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0945 1.0070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3801 0.5945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6656 1.0070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1190 0.7521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3740 -0.0325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1586 -0.2875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1586 -1.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7717 -1.6645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6002 -2.4715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8155 -2.7264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2024 -2.1744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3740 -1.3674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1190 2.0870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6656 1.8320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1109 -0.7000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6040 1.4195 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 16 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
16 5 2 0
6 7 1 0
6 18 2 0
7 8 1 0
7 17 2 0
9 8 1 0
10 9 2 0
14 9 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 17 1 0
16 15 1 0
15 18 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 234.26Molecular Weight (Monoisotopic): 234.0905AlogP: 3.11#Rotatable Bonds: 1Polar Surface Area: 57.36Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.10CX Basic pKa: 3.94CX LogP: 2.99CX LogD: 2.99Aromatic Rings: 4Heavy Atoms: 18QED Weighted: 0.53Np Likeness Score: -1.18
References 1. McBride CM, Renhowe PA, Heise C, Jansen JM, Lapointe G, Ma S, Piñeda R, Vora J, Wiesmann M, Shafer CM.. (2006) Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases., 16 (13): [PMID:16603352 ] [10.1016/j.bmcl.2006.03.069 ]